- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Bromonitrobenzene is a type of pharmaceutical intermediate used in the production of various drugs and medicines. It is a colorless, crystalline solid with a melting point of around 80°C. It is a highly reactive compound and is used in the synthesis of a variety of organic compounds. Bromonitrobenzene is used in the production of pharmaceuticals such as antibiotics, antifungals, and anti-inflammatory drugs. It is also used in the production of dyes, pigments, and other organic compounds.
Bromonitrobenzene is a key component in the production of pharmaceuticals and is used in a variety of processes. It is used in the synthesis of active pharmaceutical ingredients (APIs) and in the production of intermediates. It is also used in the production of drug delivery systems, such as liposomes and nanoparticles.
The bromonitrobenzene market is highly competitive and is dominated by a few large players. The market is characterized by the presence of a few large players, such as Merck, BASF, and Sigma-Aldrich, who have a significant share of the market. Other players in the market include AkzoNobel, Clariant, and Evonik.
Companies in the bromonitrobenzene market include Merck, BASF, Sigma-Aldrich, AkzoNobel, Clari Show Less Read more